"Aminoquinolines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Quinolines substituted in any position by one or more amino groups.
| Descriptor ID |
D000634
|
| MeSH Number(s) |
D03.633.100.810.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminoquinolines".
Below are MeSH descriptors whose meaning is more specific than "Aminoquinolines".
This graph shows the total number of publications written about "Aminoquinolines" by people in this website by year, and whether "Aminoquinolines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminoquinolines" by people in Profiles.
-
Khong A, Cleaver AL, Fahmi Alatas M, Wylie BC, Connor T, Fisher SA, Broomfield S, Lesterhuis WJ, Currie AJ, Lake RA, Robinson BW. The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40. BMC Cancer. 2014 Dec 17; 14:969.
-
Liu H, Tuchinda P, Fishelevich R, Harberts E, Gaspari AA. Human in vitro skin organ culture as a model system for evaluating DNA repair. J Dermatol Sci. 2014 Jun; 74(3):236-41.
-
Rubenzik MK, Schwartz LR, Humphreys TR. Large facial basal cell carcinoma treated with multimodal combination therapy. Cutis. 2011 Oct; 88(4):182-4.
-
Fishelevich R, Zhao Y, Tuchinda P, Liu H, Nakazono A, Tammaro A, Meng TC, Lee J, Gaspari AA. Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells. J Immunol. 2011 Aug 15; 187(4):1664-73.
-
O'Brien K, Fitzgerald D, Rostami A, Gran B. The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2010 Apr 15; 221(1-2):107-11.
-
Gaspari AA. Mechanism of action and other potential roles of an immune response modifier. Cutis. 2007 Apr; 79(4 Suppl):36-45.
-
Gaspari AA, Sauder DN. Immunotherapy of basal cell carcinoma: evolving approaches. Dermatol Surg. 2003 Oct; 29(10):1027-34.
-
Do JH, McLaughlin SS, Gaspari AA. Topical imiquimod therapy for cutaneous T-cell lymphoma. Skinmed. 2003 Sep-Oct; 2(5):316-8.